{
    "medicine_id": "70f1546fb7170079e08e4c974e98133d05902b49",
    "platform_id": "DB13583",
    "metadata": {
        "name": "Decontractyl Baume Ointment",
        "composition": "Mephenesin",
        "clinical_particulars": {
            "therapeutic_indications": "Mephenesin was used for the treatment of muscle spasticity in diseases like Parkinson s or Multiple Sclerosis",
            "contraindications": {
                "disease": "Mephenesin can produce hemolysis leading to hemoglobinuria with intravenous administration of concentrations greater than 10 A32760 As a central nervous system depressant it can also produce paralysis and respiratory depression",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mephenesin reduced neuronal excitability leading to decreases action potentials to muscle fibers which ultimately produces a reduction in spasticity A32761",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Mephenesin"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Mephenesin"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Lasmiditan is combined with Mephenesin"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Mephenesin is combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Mephenesin is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "Magnesium can cause a decrease in the absorption of Mephenesin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Mephenesin"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "Mephenesin may increase the central nervous system depressant CNS depressant activities of Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Mephenesin is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}